# Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis

Study · id `cardio:ct-nct02545231` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02545231](<https://clinicaltrials.gov/study/NCT02545231>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02545231

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.

## Technical summary

Registry record NCT02545231. Randomized; double masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2018-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1000 participants (enrolled count; ClinicalTrials.gov record NCT02545231, source copy `cardio:ctgov-nct02545231-2020-11-10`, retrieved 2026-10-31)
- Start date: 2013-02 (registry gives no type) (ClinicalTrials.gov record NCT02545231, source copy `cardio:ctgov-nct02545231-2020-11-10`, retrieved 2026-10-31)
- Primary completion: 2018-12 (actual) (ClinicalTrials.gov record NCT02545231, source copy `cardio:ctgov-nct02545231-2020-11-10`, retrieved 2026-10-31)
- Completion: 2020-08 (actual) (ClinicalTrials.gov record NCT02545231, source copy `cardio:ctgov-nct02545231-2020-11-10`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT02545231, source copy `cardio:ctgov-nct02545231-2020-11-10`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02545231-2020-11-10`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
- Acronym: ELEVATE
- Condition: Atherosclerosis
- Condition: Neointima
- Condition: Angina
- Intervention (Drug): Pitavastatin 1mg
- Intervention (Drug): Pitavastatin 4mg
- Intervention (Drug): Placebo
- Lead sponsor: Korea University Anam Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Pitavastatin (`cardio:pitavastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Korea University Anam Hospital (`cardio:org-korea-university-anam-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of lowest-dose vs. highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: an optical coherence tomography analysis (`cardio:pubmed-30047013`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 81e462ec9f270e58e89a5df6625a82a1f3ab60a80ddb4a683f7cb42c64bf6dc1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
